Anoro Ellipta

Anoro Ellipta is used to treat a lung disease called chronic obstructive pulmonary disease (COPD). Anoro Ellipta is not to be used to relieve acute symptoms or replace a rescue inhaler.

Anoro Ellipta Overview

Reviewed: December 18, 2013

Anoro Ellipta is a prescription medication used for the long-term maintenance treatment of chronic obstructive pulmonary disease (COPD).

This medication is a combination of umeclidinium, an inhaled anticholinergic that affects the muscles around the large airways and stops the muscles from tightening, and vilanterol, a long-acting beta2-adrenergic agonist (LABA) that improves breathing by relaxing the muscles of the airways to allow more air to flow into and out of the lungs.

Anoro Ellipta comes as an inhaler to be inhaled into the lungs, once daily.

The most common side effects reported include sore throat, sinus infection, lower respiratory tract infection, constipation, diarrhea, pain in extremity, muscle spasms, neck pain, and chest pain.

How was your experience with ?

First, a little about yourself

Tell us about yourself in a few words?

What tips would you provide a friend before taking ?

What are you taking for?

Choose one
  • Other

How long have you been taking it?

Choose one
  • Less than a week
  • A couple weeks
  • A month or so
  • A few months
  • A year or so
  • Two years or more

How well did work for you?

Did you experience many side effects while taking this drug?

How likely would you be to recommend to a friend?

Anoro Ellipta Cautionary Labels


Uses of Anoro Ellipta

Anoro Ellipta is a prescription medicine used to treat COPD. COPD is a chronic lung disease that includes chronic bronchitis, emphysema, or both. 
This medication may be prescribed for other uses. Ask your doctor or pharmacist for more information.


Anoro Ellipta Drug Class

Side Effects of Anoro Ellipta

Serious side effects have been reported. See "Precautions".

Common side effects of Anoro Ellipta include: 
  • sore throat 
  • sinus infection   
  • lower respiratory infection 
  • common cold symptoms 
  • constipation 
  • diarrhea 
  • pain in your arms or legs 
  • muscle spasms 
  • neck pain 
  • chest pain 

Tell your healthcare provider about any side effect that bothers you or that does not go away. 

These are not all the side effects with Anoro Ellipta. Ask your healthcare provider or pharmacist for more information. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. 

Anoro Ellipta Interactions

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. 

Anoro Ellipta and certain other medicines may interact with each other. This may cause serious side effects. Especially tell your healthcare provider if you take: 
This is not a complete list of Anoro Ellipta drug interactions. Ask your doctor or pharmacist for more information.

Anoro Ellipta Precautions

Anoro Ellipta is only approved for use in chronic obstructive pulmonary disease (COPD). This medication is NOT approved for use in asthma
Anoro Elliptal can cause serious side effects, including: 
  • People with asthma who take long-acting beta2-adrenergic agonist (LABA) medicines, such as vilanterol, have an increased risk of death from asthma problems. 
  • It is not known if LABA medicines, such as vilanterol, increase the risk of death in people with COPD. 
  • Call your healthcare provider if breathing problems worsen over time while using Anoro Ellipta. You may need different treatment.
  • Sudden breathing problems immediately after inhaling your medicine 
  • Serious allergic reactions. Call your healthcare provider or get emergency medical care if you get any of the following symptoms of a serious allergic reaction: 
    • rash 
    • hives 
    • swelling of the face, mouth, and tongue 
    • breathing problems 
  • Effects on your heart
    • increased blood pressure 
    • a fast and/or irregular heartbeat 
    • chest pain 
  • Effects on your nervous system 
    • tremor 
    • nervousness 
  • New or worsened eye problems including acute narrow-angle glaucomaAcute narrow-angle glaucoma can cause permanent loss of vision if not treated. Symptoms of acute narrow-angle glaucoma may include: 
    • eye pain or discomfort 
    • nausea or vomiting 
    • blurred vision 
    • seeing halos or bright colors around lights 
    • red eyes 
  • Urinary retention. People who take Anoro Ellipta may develop new or worse urinary retention. Symptoms of urinary retention may include: 
    • difficulty urinating 
    • painful urination 
    • urinating frequently 
    • urination in a weak stream or drips 
  • Changes in laboratory blood levels, including high levels of blood sugar (hyperglycemia) and low levels of potassium (hypokalemia) 

Get emergency medical care if: 

  • your breathing problems worsen quickly 
  • you use your rescue inhaler, but it does not relieve you

Do not use Anoro Ellipta if you: 

  • have a severe allergy to milk proteins. Ask your healthcare provider if you are not sure. 
  • are allergic to Anoro Ellipta or any of the ingredients in this medication

Anoro Ellipta Food Interactions

Medications can interact with certain foods. In some cases, this may be harmful and your doctor may advise you to avoid certain foods. In the case of Anoro Ellipta, there are no specific foods that you must exclude from your diet when receiving this medication.

Inform MD

Tell your healthcare provider about all of your health conditions, including if you: 

  • have heart problems 
  • have high blood pressure 
  • have seizures 
  • have thyroid problems 
  • have diabetes 
  • have liver problems 
  • have eye problems such as glaucoma. Anoro Ellipta may make your glaucoma worse. 
  • have prostate or bladder problems, or problems passing urine. Anoro Ellipta may make these problems worse. 
  • are allergic to any of the ingredients in Anoro Ellipta, any other medicines, or food products.
  • have any other medical conditions 
  • are pregnant or planning to become pregnant. It is not known if Anoro Ellipta may harm your unborn baby. 
  • are breastfeeding. It is not known if the medicines in Anoro Ellipta pass into your milk and if they can harm your baby. 
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. 

Anoro Ellipta and Pregnancy

Tell your doctor if you are pregnant or plan to become pregnant.

The FDA categorizes medications based on safety for use during pregnancy. Five categories - A, B, C, D, and X, are used to classify the possible risks to an unborn baby when a medication is taken during pregnancy.

This medication falls into category C. There are no good studies that have been done in humans with Anoro Ellipta. However, animal reproduction studies demonstrated no evidence of adverse effects. Because animal reproduction studies are not always predictive of human response, this medication should be used during pregnancy only if the potential benefit justifies the potential risk.

Anoro Ellipta and Lactation

Tell your doctor if you are breastfeeding or plan to breastfeed.

It is not known if Anoro Ellipta passes into your breast milk. You and your healthcare provider should decide if you will breastfeed while taking this medication.

Anoro Ellipta Usage

  • Do not use Anoro Ellipta unless your healthcare provider has taught you how to use the inhaler and you understand how to use it correctly. 
  • Use Anoro Ellipta exactly as your healthcare provider tells you to use it. Do not use Anoro Ellipta more often than prescribed. 
  • Use 1 inhalation of Anoro Ellipta 1 time each day. Use Anoro Ellipta at the same time each day. 
  • If you miss a dose of Anoro Ellipta, take it as soon as you remember. Do not take more than 1 inhalation each day. Take your next dose at your usual time. 
  • Do not take 2 doses at one time. 
  • If you take too much Anoro Ellipta, call your healthcare provider or go to the nearest hospital emergency room right away if you have any unusual symptoms, such as worsening shortness of breath, chest pain, increased heart rate, or shakiness. 
  • Do not use other medicines that contain a LABA or an anticholinergic for any reason. Ask your healthcare provider or pharmacist if any of your other medicines are LABA or anticholinergic medicines. 
  • Do not stop using Anoro Ellipta unless told to do so by your healthcare provider because your symptoms might get worse. Your healthcare provider will change your medicines as needed. 
  • Anoro Ellipta does not relieve sudden symptoms. Always have a rescue inhaler with you to treat sudden symptoms. If you do not have a rescue inhaler, call your healthcare provider to have one prescribed for you. 

Call your healthcare provider or get medical care right away if: 

  • your breathing problems get worse 
  • you need to use your rescue inhaler more often than usual 
  • your rescue inhaler does not work as well to relieve your symptoms 

Anoro Ellipta Dosage

Take this medication exactly as prescribed by your doctor. Follow the directions on your prescription label carefully.

The recommended dose of Anoro Ellipta is 1 inhalation once daily inhaled orally.


Anoro Ellipta Overdose

If you take too much Anoro Ellipta call your healthcare provider or go to the nearest hospital emergency room right away if you have any unusual symptoms, such as worsening shortness of breath, chest pain, increased heart rate, or shakiness. 

Other Requirements

  • Store Anoro Ellipta at room temperature between 68°F and 77°F (20°C and 25°C). Keep in a dry place away from heat and sunlight. 
  • Store Anoro Ellipta in the unopened foil tray and only open when ready for use. 
  • Safely throw away Anoro Ellipta in the trash 6 weeks after you open the foil tray or when the counter reads “0”, whichever comes first. Write the date you open the tray on the label on the inhaler. 
  • Keep Anoro Ellipta and all medicines out of the reach of children

Anoro Ellipta FDA Warning

Long-acting beta2-adrenergic agonists (LABA) increase the risk of asthma-related death. Data from a large placebo-controlled US trial that compared the safety of another LABA (salmeterol) with placebo added to usual asthma therapy showed an increase in asthma-related deaths in subjects receiving salmeterol. This finding with salmeterol is considered a class effect of LABA, including vilanterol, an active ingredient in Anoro Ellipta (Umeclidinium and Vilanterol)
The safety and efficacy of Anoro Ellipta (Umeclidinium and Vilanterol) in patients with asthma have not been established. Anoro Ellipta (Umeclidinium and Vilanterol) is not indicated for the treatment of asthma.